KAICO Ltd.
PrivateLast Round
Series B
Apr 15, 2025
Est. Valuation
$18.39M
Total Funding Raised
$10.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KAICO Ltd. is a biotechnology company that specializes in developing and manufacturing proteins, vaccines, and diagnostics using a proprietary silkworm-based production platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, D2C Brands
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KAICO Ltd. Comparables
Compare KAICO Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seteka Corporation | 82% | |
| Rimco Co., Ltd. | 81% | |
| 株式会社シルクルネッサンス | 80% |
KAICO Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 15, 2025 | ||||
| Series A Extension | Jan 19, 2024 | ||||
| Series A Extension | Dec 15, 2021 | ||||
| Series A | May 22, 2020 | ||||
| Seed | Oct 1, 2018 |
Key People
Founding team and executive leadership
KAICO Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ITOCHU Technology Ventures | Series A Extension, Series B |
| Mizuho Capital | Series A Extension |
| Higin Capital | Series B |
| 株式会社FFGベンチャービジネスパートナーズ | Series A Extension, Series A, Seed |
| DG Incubation | Series B |
| Tokyo Century | Series A Extension, Series A, Series B |
| 株式会社佐銀キャピタル＆コンサルティング | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Partnered with Reber Genetics to distribute KAICO Powder in Taiwan.
- Nov 11, 2025
Will exhibit at the 11th Asia Pig Veterinary Society Congress in November 2025.
Recent news
Latest coverage and updates
- is_developingJun 17, 2026
Kaico Ltd. is developing oral vaccines for both human and animal health applications.
KAICO Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KAICO Ltd.'s valuation, stock price, and market status.
Is KAICO Ltd. a public or private company?
KAICO Ltd. is a private company.
What is the current stock price of KAICO Ltd.?
KAICO Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is KAICO Ltd. worth (valuation)?
Valuation information for KAICO Ltd. is not publicly available.
Can I buy KAICO Ltd. stock?
KAICO Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KAICO Ltd.'s last funding round?
KAICO Ltd.'s most recent funding round was Series B on April 15, 2025.
Who are the main investors in KAICO Ltd.?
Key investors in KAICO Ltd. include 株式会社FFGベンチャービジネスパートナーズ.
Will KAICO Ltd. IPO soon?
No public IPO plans have been announced for KAICO Ltd..
How can I track KAICO Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KAICO Ltd.'s secondary market activity and sign up for updates.